Chiral solvating agents for cyanohydrins and carboxylic acids LS Moon, M Pal, Y Kasetti, PV Bharatam, RS Jolly The Journal of organic chemistry 75 (16), 5487-5498, 2010 | 55 | 2010 |
Tyr1-ψ[(Z)CF═CH]-Gly2 Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin RA Altman, KK Sharma, LG Rajewski, PC Toren, MJ Baltezor, M Pal, ... ACS chemical neuroscience 9 (7), 1735-1742, 2018 | 43 | 2018 |
Synthesis and Opioid Activity of Tyr1-[(Z)CF=CH]-Gly2 and Tyr1-[(S)/(R)-CF3CH-NH]-Gly2 Leu-enkephalin Fluorinated Pep-tidomimetics. ARA Karad SN, Pal M, Prisinzano TE, Crowley RS ChemMedChem, 2017 | 37 | 2017 |
A catalase–peroxidase for oxidation of β-lactams to their (R)-sulfoxides S Sangar, M Pal, LS Moon, RS Jolly Bioresource technology 115, 102-110, 2012 | 34 | 2012 |
Discovery and characterization of 2, 5-substituted benzoic acid dual inhibitors of the anti-apoptotic Mcl-1 and Bfl-1 proteins KJ Kump, L Miao, ASA Mady, NH Ansari, UK Shrestha, Y Yang, M Pal, ... Journal of medicinal chemistry 63 (5), 2489-2510, 2020 | 33 | 2020 |
Rational design and synthesis of substrate–product analogue inhibitors of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis M Pal, M Khanal, R Marko, S Thirumalairajan, SL Bearne Chemical Communications 52 (13), 2740-2743, 2016 | 24 | 2016 |
Synthesis of coenzyme A thioesters using methyl acyl phosphates in an aqueous medium M Pal, SL Bearne Organic & biomolecular chemistry 12 (48), 9760-9763, 2014 | 23 | 2014 |
Inhibition of glutamate racemase by substrate–product analogues M Pal, SL Bearne Bioorganic & Medicinal Chemistry Letters 24 (5), 1432-1436, 2014 | 21 | 2014 |
Bioreduction of methyl heteroaryl and aryl heteroaryl ketones in high enantiomeric excess with newly isolated fungal strains M Pal, G Srivastava, LS Moon, RS Jolly Bioresource technology 118, 306-314, 2012 | 19 | 2012 |
A highly efficient designer cell for enantioselective reduction of ketones G Srivastava, M Pal, S Kaur, RS Jolly Catalysis Science & Technology 5 (1), 105-108, 2015 | 15 | 2015 |
Potent dialkyl substrate-product analogue inhibitors and inactivators of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis by rational design M Pal, NM Easton, H Yaphe, SL Bearne Bioorganic Chemistry 77, 640-650, 2018 | 14 | 2018 |
Biocatalyzed asymmetric reduction of benzils to either benzoins or hydrobenzoins: pH dependent switch M Pal, G Srivastava, AN Sharma, S Kaur, RS Jolly Catalysis Science & Technology 5 (8), 4017-4028, 2015 | 11 | 2015 |
Preparation of heterocycles as PI3K-alpha inhibitors and methods of use thereof AT Boezio, M Alexander, CG Fridrich, H Gunaydin, LV Dipietro, ... WO2023039532, 2023 | 4 | 2023 |
Pi3k-alpha inhibitors and methods of use thereof A Boezio, AM Taylor, CG Fridrich, H Gunaydin, LV DiPietro, LCT Pierce, ... US Patent App. 18/578,082, 2025 | | 2025 |
Pi3k-alpha inhibitors and methods of use thereof A Boezio, LV DiPietro, CG Fridrich, H Gunaydin, R Kurukulasuriya, ... US Patent App. 17/921,580, 2024 | | 2024 |
Palladium-Catalyzed Dearomatization of Benzothiophenes: Isolation and Functionalization of a Discrete Dearomatized Intermediate AJ Intelli, M Pal, M Selvaraju, RA Altman Synthesis 55 (21), 3568-3574, 2023 | | 2023 |
Abstract LB-226: Discovery of small molecule Mcl-1 and Bfl-1 inhibitors KJ Kump, L Miao, AA Mady, NH Ansari, UK Shrestha, Y Yang, M Pal, ... Cancer Research 80 (16_Supplement), LB-226-LB-226, 2020 | | 2020 |
New biocatalysts for asymmetric reduction of heteroaryl ketones and 1, 2-Diketones and baeyer villiger oxidation of bicycle [3.2. 0] hept-2-en-6-one. M Pal CSIR-IMTECH, Chandigarh/Jawaharlal Nehru University, New Delhi: India, 2011 | | 2011 |